Serum amyloid A: A marker of adiposity-induced low-grade inflammation but not of metabolic status

Obesity

Volumn 14, Issue 2, 2006, Pages 309-318

  Poitou, Christine ^a,b,c   Coussieu, Christiane ^d   Rouault, Christine ^a,b,c   Coupaye, Muriel ^c   Cancello, Raffaella ^a,b,c   Bedel, Jean François ^a,b,c   Gouillon, Madeleine ^a,b,c   Bouillot, Jean Luc ^d   Oppert, Jean Michel ^b,c   Basdevant, Arnaud ^a,b,c   Clément, Karine ^a,b,c,d  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔTEL DIEU   (France)

Author keywords

Adipose tissue; Inflammation; Insulin resistance; Serum amyloid A; Weight loss

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; SERUM AMYLOID A;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; LIVER; MALE; METABOLISM; MORBID OBESITY; PHYSIOLOGY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; SECRETION; STOMACH BYPASS; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; BIOLOGICAL MARKERS; ENERGY METABOLISM; FEMALE; GASTRIC BYPASS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIVER; MALE; OBESITY, MORBID; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; WEIGHT LOSS;

EID: 33748170670     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.40     Document Type: Article

References (37)

1. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92: 347-55.
2. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60:349-56.
3. Klaus S. Adipose tissue as a regulator of energy balance. Curr Drug Targets. 2004;5:241-50.
4. Rajala MW, Scherer PE. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003;144:3765-73.
5. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S25-8.
6. Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S53-5.
7. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003; 144:2195-200.
8. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005; 111:1448 -54.
9. Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14:589-600.
10. Clement K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004;18:1657-69.
11. Sjoholm, K, Palming J, Olofsson LE, et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab. 2004;90:2233-9.
12. Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia. 2005;48:519-28.
13. van Dielen FM, van't Veer C, Schols AM, Soeters PB, Buurman WA, Greve JW. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals, Int J Obes Relat Metab Disord. 2001;25:1759-66.
14. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol. 2000;7:64-9.
15. Johnson BD, Kip KE, Marroquin OC, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004; 109:726-32.
16. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem. 2001;276: 42077-83.
17. Walder K, Kantham L, McMillan JS, et al. Tanis: a link between type 2 diabetes and inflammation? Diabetes. 2002; 51:1859-66.
18. Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis. 2003;166:387-94.
19. Karlsson HK, Tsuchida H, Lake S, Koistinen HA, Krook A. Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects. Diabetes. 2004;53: 1424-8.
20. Poitou C, Lacorte JM, Coupaye M, et al. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes Surg. 2005;15:11-23.
21. Clement K, Viguerie N, Diehn M, et al. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Res. 2002; 12:281-91.
22. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-10.
23. Holdstock C, Lind L, Engstrom BE, et al. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Int J Obes (Land). 2005;29:1275-80.
24. van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004;89:4062-8.
25. Maachi M, Pieroni L, Bruckert E, et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord. 2004;28:993-7.
26. Jensen LE, Whitehead AS. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J. 1998;334:489-503.
27. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-808.
28. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-30.
29. Curat CA, Miranville A, Sengenes C, et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes. 2004; 53:1285-92.
30. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care. 2005; 8:347-54.
31. Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54:2277-86.
32. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem. 1986;261:9644-51.
33. Hamano M, Saito M, Eto M, et al. Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease. Ann Clin Biochem. 2004;41:125-9.
34. Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Anna Rev Nutr. 2004(Epub).
35. Vazquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90:316-22.
36. Muscelli E, Mingrone G, Camastra S, et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med. 2005;118:51-7.
37. Bastard JP, Rabasa-Lhoret R, Maachi M, et al. What kind of simple fasting index should be used to estimate insulin sensitivity in humans? Diabetes Metab. 2003;29:285-8.